Literature DB >> 3098915

Fulminant hepatitis in asymptomatic hepatitis B surface antigen carriers in Greece.

N C Tassopoulos, G J Papaevangelou, A Roumeliotou-Karayannis, A Smedile, R Engle, J R Ticehurst, S M Feinstone, R H Purcell.   

Abstract

Eleven male fulminant hepatitis (FH) patients (mean age: 47.7 +/- 16 years) positive for hepatitis B surface antigen (HBsAg) but negative for IgM antibody to hepatitis B core antigen (IgM anti-HBc) were admitted consecutively to the Athens Hospital for Infectious Diseases between May 1981 and November 1983. Because of the absence of IgM anti-HBc, determined by an enzyme immunoassay, these patients were considered to be HBsAg carriers with a superimposed acute hepatitis. Three of the 11 patients received immunosuppressive chemotherapy during the six months before the onset of the acute hepatitis. None of the patients was homosexual or a drug addict. Infection with hepatitis A virus (HAV), hepatitis B virus (HBV), or hepatitis delta virus (HDV) was detected with serologic markers and/or molecular hybridization techniques. Fulminant hepatitis was attributed to spontaneous reactivation of chronic hepatitis B in four patients, chemotherapy-induced reactivation of chronic hepatitis B in three patients, HDV superinfection in one patient and possible superinfection by non-A, non-B agent(s), HDV, or HDV-like agents in three patients. Reactivation of chronic hepatitis B was an important cause of apparent acute hepatitis in heterosexual male HBsAg carriers from an area with a high prevalence of HBV infection.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3098915     DOI: 10.1002/jmv.1890200410

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  5 in total

1.  Viral superinfection in previously unrecognized chronic carriers of hepatitis B virus with superimposed acute fulminant versus nonfulminant hepatitis.

Authors:  C M Chu; C T Yeh; Y F Liaw
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

2.  Etiology of acute hepatitis superimposed on hepatitis B surface antigen carriage.

Authors:  N C Tassopoulos; P Nikolakakis; P Zorbas; H Stefatou; M Koutelou; A Karanassou; A Tagaris; P Kalafatas
Journal:  Infection       Date:  1989 Mar-Apr       Impact factor: 3.553

3.  The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state.

Authors:  C M Chu; Y F Liaw
Journal:  Infection       Date:  1990 Jul-Aug       Impact factor: 3.553

4.  Recovery from life-threatening, corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.

Authors:  F ter Borg; S Smorenburg; R A de Man; R C Rietbroek; R A Chamuleau; E A Jones
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

5.  Hepatitis B reactivation among 1962 patients with hematological malignancy in Taiwan.

Authors:  Chien-Yuan Chen; Feng-Ming Tien; Aristine Cheng; Shang-Yi Huang; Wen-Chien Chou; Ming Yao; Jih-Luh Tang; Hwei-Fang Tien; Wang-Huei Sheng
Journal:  BMC Gastroenterol       Date:  2018-01-08       Impact factor: 3.067

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.